Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This study is designed as Phase II/III. Phase II is aimed to evaluate safety and efficacy of
IRIS, and feasibility of FOLFIRI. Phase III is aimed to verify inferiority of the progression
free survival of IRIS in comparison with FOLFIRI.